Acquisition and Cancellation of 3rd Series Convertible Bonds Before Maturity


  • Acquired 1.5 billion KRW face value of 3rd series unsecured private convertible bonds via OTC purchase at 1,604,340,000 KRW (approx. 7% premium) due to bondholder's early redemption right exercise
  • Acquired bonds to be cancelled at Korea Securities Depository
  • Funding source: own capital
  • Conversion price per share: 3,396 KRW (adjusted for 2025 rights offering)
  • Related disclosures: 2024-02-06 CB issuance decision, 2024-02-08 issuance result, 2024-09-09 and 2025-03-10 conversion price adjustment

KOSDAQ Filing Information


  • Filing: Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) Before Maturity After Issuance
  • Company: Precision Biosensor (335810)
  • Submission: Precision Biosensor Inc.
  • Receipt: 05-08-2026
  • Under KRX KOSDAQ Market Division